Suppr超能文献

弥漫型与肠型组织学类型对胃癌患者的预后价值:一项系统评价和荟萃分析。

Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.

作者信息

Petrelli Fausto, Berenato Rosa, Turati Luca, Mennitto Alessia, Steccanella Francesca, Caporale Marta, Dallera Pierpaolo, de Braud Filippo, Pezzica Ezio, Di Bartolomeo Maria, Sgroi Giovanni, Mazzaferro Vincenzo, Pietrantonio Filippo, Barni Sandro

机构信息

Medical Oncology Unit, Oncology Department, ASST Bergamo Ovest, Treviglio (BG), Italy.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

出版信息

J Gastrointest Oncol. 2017 Feb;8(1):148-163. doi: 10.21037/jgo.2017.01.10.

Abstract

BACKGROUND

There are two distinct types of gastric carcinoma (GC), intestinal, more frequently sporadic and linked to environmental factors, and diffuse (undifferentiated) that is highly metastatic and characterized by rapid disease progression and a poor prognosis. However, there are many conflicting data in the literature concerning the association between histology and prognosis in GC. This meta-analysis was performed to provide demonstration if histology according to Lauren classification is associated with different prognosis in patients with GC.

METHODS

We searched PubMed, the Cochrane Library, SCOPUS, Web of Science, CINAHL, and EMBASE for all eligible studies. The combined hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs) in terms of overall survival (OS) were evaluated.

RESULTS

A total of 73 published studies including 61,468 patients with GC were included in this meta-analysis. Our analysis indicates that GC patients with diffuse-type histology have a worst prognosis than those with intestinal subgroup in all studies (HR 1.23; 95% CI, 1.17-1.29; P<0.0001), in both loco-regional confined (HR 1.21; 95% CI, 1.12-1.30; P<0.0001) and advanced disease (HR 1.25; 95% CI, 1.046-1.50; P=0.014), in Asiatic (HR 1.2; 95% CI, 1.14-1.27; P<0.0001) and Western patients (HR 1.3; 95% CI, 1.19-1.41; P<0.0001), and in those not exposed (HR 1.15; 95% CI, 1.07-1.24; P<0.0001) or exposed (HR 1.27; 95% CI, 1.17-1.37; P<0.0001) to (neo)adjuvant therapy.

CONCLUSIONS

Our results indicated that histology might be a useful prognostic marker for both early and advanced GC patients, with intestinal-type associated with a better outcome. This information could be used for stratification purpose in future clinical trials.

摘要

背景

胃癌(GC)有两种不同类型,即肠型,更常见为散发性,与环境因素有关;以及弥漫型(未分化型),具有高度转移性,其特征为疾病进展迅速且预后不良。然而,关于GC组织学与预后之间的关联,文献中有许多相互矛盾的数据。进行这项荟萃分析是为了证实根据劳伦分类法的组织学是否与GC患者的不同预后相关。

方法

我们在PubMed、Cochrane图书馆、SCOPUS、科学网、CINAHL和EMBASE中检索了所有符合条件的研究。评估了总生存期(OS)方面的合并风险比(HRs)及其相应的95%置信区间(CIs)。

结果

本荟萃分析共纳入73项已发表研究,包括61468例GC患者。我们的分析表明,在所有研究中,弥漫型组织学的GC患者预后比肠型亚组患者更差(HR 1.23;95% CI,1.17 - 1.29;P < 0.0001),在局部区域局限型(HR 1.21;95% CI,1.12 - 1.30;P < 0.0001)和晚期疾病(HR 1.25;95% CI,1.046 - 1.50;P = 0.014)患者中均如此,在亚洲患者(HR 1.2;95% CI,1.14 - 1.27;P < 0.0001)和西方患者(HR 1.3;95% CI,1.19 - 1.41;P < 0.0001)中也是如此,在未接受(HR 1.15;95% CI,1.07 - 1.24;P < 0.0001)或接受(HR 1.27;95% CI,1.17 - 1.37;P < 0.0001)(新)辅助治疗的患者中同样如此。

结论

我们的结果表明,组织学可能是早期和晚期GC患者有用的预后标志物,肠型与较好的预后相关。该信息可用于未来临床试验的分层目的。

相似文献

2
Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study.
Gastric Cancer. 2023 Sep;26(5):708-720. doi: 10.1007/s10120-023-01398-x. Epub 2023 Jun 3.
4
Prognostic and pathological impact of tumor budding in gastric cancer: A systematic review and meta-analysis.
World J Gastrointest Oncol. 2019 Oct 15;11(10):898-908. doi: 10.4251/wjgo.v11.i10.898.
5
Different prognostic significance of signet ring cell histology for early and advanced gastric cancer patients: a systematic review and meta-analysis.
Expert Rev Gastroenterol Hepatol. 2020 Jun;14(6):499-509. doi: 10.1080/17474124.2020.1769476. Epub 2020 May 24.
7
Prognostic Significance of Molecular Analysis of Peritoneal Fluid for Patients with Gastric Cancer: A Meta-Analysis.
PLoS One. 2016 Mar 17;11(3):e0151608. doi: 10.1371/journal.pone.0151608. eCollection 2016.
8
Prognostic value of microRNAs in gastric cancer: a meta-analysis.
Oncotarget. 2017 Jun 21;8(33):55489-55510. doi: 10.18632/oncotarget.18590. eCollection 2017 Aug 15.
9
Potential Role of Glucose Transporter-1 Expression in Gastric Cancer: A Meta-Analysis and Systematic Review.
Iran J Public Health. 2020 Nov;49(11):2044-2053. doi: 10.18502/ijph.v49i11.4719.
10
Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis.
Onco Targets Ther. 2016 May 27;9:3205-12. doi: 10.2147/OTT.S99461. eCollection 2016.

引用本文的文献

2
Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer.
Research (Wash D C). 2025 Aug 25;8:0838. doi: 10.34133/research.0838. eCollection 2025.
3
Immunotherapy for diffuse gastric cancer: challenges and new avenues.
NPJ Precis Oncol. 2025 Jul 21;9(1):247. doi: 10.1038/s41698-025-01052-y.
4
infection negatively affects response of gastric cancer to immunotherapy.
Ann Gastroenterol. 2025 May-Jun;38(3):262-269. doi: 10.20524/aog.2025.0966. Epub 2025 Apr 28.
6
Investigating combined hypoxia and stemness indices for prognostic transcripts in gastric cancer: Machine learning and network analysis approaches.
Biochem Biophys Rep. 2024 Dec 19;41:101897. doi: 10.1016/j.bbrep.2024.101897. eCollection 2025 Mar.
8
Histopathological response to chemotherapy and survival of mucinous type gastric cancer.
J Natl Cancer Inst. 2025 Feb 1;117(2):253-261. doi: 10.1093/jnci/djae227.
9
Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics.
Target Oncol. 2024 Nov;19(6):845-865. doi: 10.1007/s11523-024-01097-2. Epub 2024 Sep 13.

本文引用的文献

1
Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hum Pathol. 2015 Dec;46(12):1872-80. doi: 10.1016/j.humpath.2015.08.004. Epub 2015 Aug 24.
2
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer.
Gastric Cancer. 2016 Jan;19(1):31-41. doi: 10.1007/s10120-015-0537-5. Epub 2015 Sep 2.
4
Short-term and long-term risk factors in gastric cancer.
World J Gastroenterol. 2015 Jun 7;21(21):6434-43. doi: 10.3748/wjg.v21.i21.6434.
6
Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
World J Gastroenterol. 2015 May 7;21(17):5336-44. doi: 10.3748/wjg.v21.i17.5336.
7
Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.
Gastric Cancer. 2016 Apr;19(2):412-420. doi: 10.1007/s10120-015-0495-y. Epub 2015 Apr 11.
9
Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
Pathol Res Pract. 2015 Apr;211(4):298-302. doi: 10.1016/j.prp.2014.12.015. Epub 2015 Jan 21.
10
Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer.
J Surg Res. 2015 Apr;194(2):458-463. doi: 10.1016/j.jss.2014.12.005. Epub 2014 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验